What could cause a microalbumin level of 800, indicating microalbuminuria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A microalbumin level of 800 mg/g is significantly elevated and indicates substantial kidney damage, most likely caused by uncontrolled diabetes, hypertension, or other conditions that damage the kidney's filtering system. This high level can be caused by several conditions, with diabetes being the most common cause, as it damages the kidney's filtering system, allowing albumin to leak into urine 1. Hypertension is another major cause, as increased blood pressure damages kidney blood vessels. Other potential causes include glomerulonephritis (inflammation of kidney filtering units), certain medications (NSAIDs, some antibiotics), urinary tract infections, heart failure, obesity, and autoimmune diseases like lupus.

Potential Causes and Implications

  • Uncontrolled diabetes: damages the kidney's filtering system, allowing albumin to leak into urine 1
  • Hypertension: increased blood pressure damages kidney blood vessels
  • Glomerulonephritis: inflammation of kidney filtering units
  • Certain medications: NSAIDs, some antibiotics
  • Urinary tract infections
  • Heart failure
  • Obesity
  • Autoimmune diseases: like lupus

Immediate medical evaluation is essential as this level indicates advanced kidney damage. Treatment depends on the underlying cause but typically includes blood pressure control with ACE inhibitors or ARBs (like lisinopril or losartan), blood sugar management for diabetics, dietary modifications (reduced sodium, protein, and potassium), and possibly referral to a nephrologist 1. The kidneys filter blood through tiny vessels called glomeruli, and when these structures are damaged, proteins like albumin leak into urine, which normally should be retained in the bloodstream.

Key Considerations for Management

  • Blood pressure control with ACE inhibitors or ARBs
  • Blood sugar management for diabetics
  • Dietary modifications: reduced sodium, protein, and potassium
  • Referral to a nephrologist for further evaluation and management.

From the FDA Drug Label

The primary endpoint of the study was the time to first occurrence of any one of the following events: doubling of serum creatinine, end-stage renal disease (ESRD) (need for dialysis or transplantation), or death. Almost all of the patients (96.6%) had a history of hypertension, and the patients entered the trial with a mean serum creatinine of 1.9 mg/dL and mean proteinuria (urinary albumin/creatinine) of 1808 mg/g at baseline.

The cause of a microalbumin level of 800 is not directly stated in the provided drug label. However, the label does mention that the patients in the study had a mean proteinuria (urinary albumin/creatinine) of 1808 mg/g at baseline, which suggests that diabetic nephropathy and hypertension could be contributing factors to elevated microalbumin levels.

  • Diabetic nephropathy is a possible cause of microalbuminuria, as it is a complication of diabetes that can lead to kidney damage and proteinuria.
  • Hypertension is also a potential contributing factor, as it can increase the pressure on the kidneys and lead to proteinuria. However, without more information, it is impossible to determine the specific cause of a microalbumin level of 800 in a particular patient 2.

From the Research

Possible Causes of Microalbuminuria

  • Diabetes: Microalbuminuria is a common complication in diabetic patients, and it is a marker of endothelial dysfunction and increased risk for cardiovascular morbidity and mortality 3, 4, 5.
  • Hypertension: Hypertensive patients are also at risk of developing microalbuminuria, which can be a predictor of cardiovascular disease 3, 5.
  • Kidney disease: Microalbuminuria can be a sign of kidney disease or kidney damage, and it is often used as a biomarker for enhanced risk of all-cause mortality, cardiovascular events, and end-stage renal disease 4.
  • Endothelial dysfunction: Microalbuminuria can be a manifestation of a diffuse endothelial (microvascular) injury and thereby collateral kidney damage 4.
  • Sickle cell disease: Microalbuminuria and proteinuria are noted to be a strong predictor of subsequent renal failure in people with sickle cell disease 6.

Factors that Can Increase Microalbuminuria

  • Poor blood sugar control: In diabetic patients, poor blood sugar control can increase the risk of microalbuminuria 5.
  • Uncontrolled hypertension: Uncontrolled hypertension can also increase the risk of microalbuminuria 3, 5.
  • Kidney damage: Pre-existing kidney damage can increase the risk of microalbuminuria 4.
  • Use of certain medications: Certain medications, such as ACE inhibitors, can affect microalbuminuria levels 7, 6.

Reducing Microalbuminuria

  • Aggressive blood pressure reduction: Reducing blood pressure, especially with medications that block the renin-angiotensin-aldosterone system, can help reduce microalbuminuria 5, 7.
  • Control of diabetes: Controlling blood sugar levels can help reduce microalbuminuria in diabetic patients 5.
  • Use of ACE inhibitors: ACE inhibitors have been shown to reduce microalbuminuria in diabetic patients and people with sickle cell disease 7, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Microalbuminuria: definition, detection, and clinical significance.

Journal of clinical hypertension (Greenwich, Conn.), 2004

Research

Microalbuminuria: what is it? Why is it important? What should be done about it? An update.

Journal of clinical hypertension (Greenwich, Conn.), 2007

Research

Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.